Howard J. Federoff - CEO & President, Director at Ernexa Therapeutics Inc.

Issuer-level insider activity

Role
CEO & President, Director
Issuer ticker
ERNA, ERNAW on Nasdaq
Identity Who this page is about. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Howard J. Federoff since 03 Jun 2025

Reported holdings for Howard J. Federoff in Ernexa Therapeutics Inc.

Form 4 holding CEO & President, Director

Brooklyn ImmunoTherapeutics, Inc.

Security class
Stock Option (Right to buy)
Shares / value
413,700
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Howard J. Federoff in Ernexa Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .